One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-136018
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 1 |
Affiliation: The University of Texas MD Anderson Cancer Center, University of Colorado Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Oregon Health & Science University, Rush University Medical Center, Piedmont Cancer Institute, Sylvester Comprehensive Cancer Center, University of Southern California, Norton Healthcare, University of Michigan–Ann Arbor, Hackensack University Medical Center, Roswell Park Cancer Institute, Cleveland Clinic, Vanderbilt University Medical Center, Rhizen Pharmaceuticals (Switzerland)A Multi-Center, Open Label, Phase I/II Study to Assess the Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
